Expanding access to medication assisted treatment for addiction
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Duration: March 1, 2016
to
December 31, 2023
General Issues: Alcohol & Drug Abuse , Health Issues , Medicare/Medicaid
Spending: about $840,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Medicare and Medicaid Services (CMS), Office of Natl Drug Control Policy (NDCP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Robert Zucker LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg
Chelsey Hickman CoS, Rep. Kay Granger; LA Sen. Larry Craig
CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
Donna Mullins CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa
Michael Merola Deputy CoS, Sen. Torricelli
Charla McManus LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Molly McDonnell LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance
Charla Penn LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
WINNING STRATEGIES WASHINGTON terminated an engagement in which they represented CleanSlate Centers, Inc. on Feb. 7.
Original Filing: 301543780.xml
3rd Quarter, 2023
In Q3, WINNING STRATEGIES WASHINGTON did no lobbying for CleanSlate Centers, Inc. . The report was filed on Oct. 18, 2023.
Original Filing: 301504949.xml
2nd Quarter, 2023
In Q2, WINNING STRATEGIES WASHINGTON did no lobbying for CleanSlate Centers, Inc. . The report was filed on July 19, 2023.
Original Filing: 301482864.xml
1st Quarter, 2023
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $20,000. The report was filed on April 19, 2023.
Original Filing: 301456537.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Jan. 18, 2023.
Original Filing: 301431435.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301408974.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301386230.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on April 19, 2022.
Original Filing: 301362330.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Jan. 20, 2022.
Original Filing: 301334250.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Oct. 18, 2021.
Original Filing: 301302196.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on July 19, 2021.
Original Filing: 301282201.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waiviers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on April 19, 2021.
Original Filing: 301257750.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waiviers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234286.xml
Lobbying Issues
Expanding access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210132.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on July 15, 2020.
Original Filing: 301188104.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment; COVID-19 payments to providers
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on April 17, 2020.
Original Filing: 301169234.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth and emergency reimbursement related to office-based opioid treatment
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108405.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065456.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on July 19, 2019.
Original Filing: 301050601.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Centers, Inc. , earning $30,000. The report was filed on April 16, 2019.
Original Filing: 301026133.xml
Lobbying Issues
Expanding Access to medication-assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of SUPPORT Act provisions on DATA 2000 waivers related to qualified practice settings
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006091.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction;
Agencies Lobbied
U.S. Senate
Lobbying Issues
implementation of provisions in Public Law 114-198 related to the TREAT Act; monitoring policies and regulations related to the Presidents declaration of the opioid crisis as a public health emergency under the Public Health Service Act; H.R. 3692, the Addiction Treatment Access Improvement Act; H.R. 5102, the Substance Use Disorder Workforce Loan Repayment Act; S.2680 The Opioid Crisis Response Act of 2018, Provisions related to expanding access to treatment in HR 6, Opioid Crisis Response Act and included in SUPPORT for Patients and Communities Act, designated Public Law 115-271
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991534.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction;
Agencies Lobbied
U.S. Senate
Lobbying Issues
implementation of provisions in Public Law 114-198 related to the TREAT Act; monitoring policies and regulations related to the Presidents declaration of the opioid crisis as a public health emergency under the Public Health Service Act; H.R. 3692, the Addiction Treatment Access Improvement Act; H.R. 5102, the Substance Use Disorder Workforce Loan Repayment Act; S.2680 The Opioid Crisis Response Act of 2018, Provisions related to expanding access to treatment in HR 6, Opioid Crisis Response Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on July 19, 2018.
Original Filing: 300969414.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction;
Agencies Lobbied
U.S. Senate
Lobbying Issues
implementation of provisions in Public Law 114-198 related to the TREAT Act; monitoring policies and regulations related to the Presidents declaration of the opioid crisis as a public health emergency under the Public Health Service Act; H.R. 3692, the Addiction Treatment Access Improvement Act; H.R. 5102, the Substance Use Disorder Workforce Loan Repayment Act; S.2680 The Opioid Crisis Response Act of 2018
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on April 18, 2018.
Original Filing: 300947030.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; TREAT Act (S 1455 and HR 2536), H.R. 4981, implementation of provisions in S. 524 related to the TREAT Act.monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act, H.R. 3692 the Addiction Treatment Access Improvement Act, H.R. 5102 the Substance Use Disorder Workforce Loan Repayment Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction;
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925011.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; Graham Cassidy Substitute Amendment provisions related to sud treatment and essential health benefits, implementation of provisions in S. 524 related to the TREAT Act.monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction; Graham Cassidy Substitute Amendment provisions related to sud treatment and essential health benefits, implementation of provisions in S. 524 related to the TREAT Act. monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
WINNING STRATEGIES WASHINGTON amended a lobbying report for representation of CleanSlate Center, Inc. in Q42017 on Jan. 17, 2018.
Original Filing: 300925015.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; implementation of provisions in S. 524 related to the TREAT Act.monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction; implementation of provisions in S. 524 related to the TREAT Act. monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Oct. 16, 2017.
Original Filing: 300904529.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; Graham Cassidy Substitute Amendment provisions related to sud treatment and essential health benefits, implementation of provisions in S. 524 related to the TREAT Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse
2nd Quarter, 2017
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on July 18, 2017.
Original Filing: 300886868.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; HR 1628, AHCA provisions related to sud treatment and essential health benefits, implementation of provisions in S. 524 related to the TREAT Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse
1st Quarter, 2017
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on April 21, 2017.
Original Filing: 300878513.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; HR 1628, AHCA provisions related to sud treatment and essential health benefits, implementation of provisions in S. 524 related to the TREAT Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse
4th Quarter, 2016
In Q4, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Jan. 19, 2017.
Original Filing: 300850957.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; TREAT Act (S. 1455 and H.R. 2536); H.R. 4981.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction;implementation of provisions in S. 524 related to the TREAT Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300836613.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; TREAT Act (S. 1455 and H.R. 2536); H.R. 4981
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $30,000. The report was filed on July 15, 2016.
Original Filing: 300810277.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction; TREAT Act (S. 1455 and H.R. 2536); H.R. 4981
Agencies Lobbied
U.S. Senate
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, WINNING STRATEGIES WASHINGTON lobbied for CleanSlate Center, Inc. , earning $10,000. The report was filed on April 20, 2016.
Original Filing: 300797897.xml
Lobbying Issues
Expanding access to medication assisted treatment for addiction
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse
1st Quarter, 2016
WINNING STRATEGIES WASHINGTON filed a lobbying registration on April 18, 2016 to represent CleanSlate Center, Inc., effective March 1, 2016.
Original Filing: 300794073.xml
Issue(s) they said they’d lobby about: Expanding access to medication assisted treatment for addiction .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...